Company Transcept Pharmaceuticals Inc Nasdaq
Equities
US89354M1062
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Evan Loh
CEO | Chief Executive Officer | 65 | 01/12/01 |
Director of Finance/CFO | - | 01/20/01 | |
Adam Woodrow
PSD | President | 57 | 01/14/01 |
Jonathan Light
CMP | Compliance Officer | - | 01/17/01 |
Raj Padmanabhan
CTO | Chief Tech/Sci/R&D Officer | - | 01/15/01 |
Karen McGrath
HRO | Human Resources Officer | - | 01/19/01 |
Randy Brenner
LAW | General Counsel | 51 | 03/15/03 |
Susan M. Perkins
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stacey Seltzer
BRD | Director/Board Member | 47 | 21/23/21 |
Evan Loh
CEO | Chief Executive Officer | 65 | 01/12/01 |
Adam Dilluvio
BRD | Director/Board Member | - | 21/23/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 57,322,358 | 46,807,641 ( 81.66 %) | 0 | 81.66 % |
Company contact information
Paratek Pharmaceuticals, Inc.
75 Park Plaza 3rd floor
02116-3934, Boston
+617-807-6600
http://www.paratekpharma.com![address Transcept Pharmaceuticals Inc](https://cdn.zonebourse.com/static/address/5050388.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+55.55% | 82TCr | |
+41.07% | 63TCr | |
-6.83% | 35TCr | |
+17.15% | 32TCr | |
+7.09% | 29TCr | |
+13.62% | 24TCr | |
+1.80% | 22TCr | |
+13.74% | 22TCr | |
+7.87% | 17TCr |
- Stock Market
- Equities
- PRTK Stock
- Stock
- Company Transcept Pharmaceuticals Inc